Reuters logo
BRIEF-Relevium secures updated terms for BioGanix acquisition
May 2, 2017 / 4:01 PM / in 6 months

BRIEF-Relevium secures updated terms for BioGanix acquisition

May 2 (Reuters) - Relevium Technologies Inc:

* Relevium secures improved terms for BioGanix acquisition and receives commitment letter for secured convertible debenture

* Received commitment letter from AIP Asset Management, AIP Private Capital for total of $2.25 million in secured convertible debentures

* Aggregate purchase price of US$4.45 million payable by co for acquisition of BioGanix will now consist of US$1.9 million in cash at closing

* Due to updated terms of BioGanix definitive agreement, minimum financing required for closing is now $3.5 million instead of $5 million

* Secured a “more flexible” structure for definitive asset purchase agreement for BioGanix acquisition

* Commitment letter to provide 2 year secured convertible debenture with coupon of 8% plus US libor, conversion strike price of $0.15

* Aggregate purchase price of US$4.45 million payable by co for BioGanix acquisition will now consist of US$500,000 in common shares of co Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below